These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25814352)

  • 21. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal vascular manifestations of metabolic disorders.
    Nguyen TT; Wong TY
    Trends Endocrinol Metab; 2006 Sep; 17(7):262-8. PubMed ID: 16890449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is fatty liver disease, and how does it impact heart risk?
    Duke Med Health News; 2010 May; 16(5):8. PubMed ID: 20521336
    [No Abstract]   [Full Text] [Related]  

  • 24. [Coronary circulation in physiological and pathological states].
    Tomoike H; Nakamura M
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1802-8. PubMed ID: 2236594
    [No Abstract]   [Full Text] [Related]  

  • 25. Modified metabolic syndrome criteria for identification of patients at risk of developing diabetes and coronary heart diseases: longitudinal assessment via electronic health records.
    Hivert MF; Dusseault-Bélanger F; Cohen A; Courteau J; Vanasse A
    Can J Cardiol; 2012; 28(6):744-9. PubMed ID: 22552176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
    Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
    Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of metabolic syndrome and diabetes on a high-risk population with suspected coronary artery disease.
    Timóteo AT; Mota Carmo M; Cruz Ferreira R
    Acta Med Port; 2012; 25(2):83-90. PubMed ID: 22985918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome, diabetes and lung dysfunction.
    Tiengo A; Fadini GP; Avogaro A
    Diabetes Metab; 2008 Nov; 34(5):447-54. PubMed ID: 18829364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the criteria of metabolic syndrome in predicting incident coronary disease and diabetes in Turkish adults/abdominal obesity and cardiometabolic risk].
    Onat A; Hergenç G
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):212-3. PubMed ID: 17513228
    [No Abstract]   [Full Text] [Related]  

  • 30. The adverse prognostic significance of the metabolic syndrome with and without hypertension in patients who underwent complete coronary revascularization.
    Kasai T; Miyauchi K; Kajimoto K; Kubota N; Dohi T; Kurata T; Amano A; Daida H
    J Hypertens; 2009 May; 27(5):1017-24. PubMed ID: 19381109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvascular dysfunction in the spectrum of coronary instability.
    De Caterina AR; Galiuto L; Fedele E; Crea F
    Am J Cardiol; 2011 Nov; 108(10):1513-6. PubMed ID: 21871593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension as part of the metabolic syndrome.
    Cheung B
    J Hum Hypertens; 2008 Dec; 22(12):871-4. PubMed ID: 18548089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension, insulin resistance, and the metabolic syndrome.
    Natali A; Ferrannini E
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of arterial hypertension in the scope of metabolic syndrome].
    Riazanov AS; Arakeliants AA; Iurenenv AP
    Ter Arkh; 2003; 75(3):86-8. PubMed ID: 12718232
    [No Abstract]   [Full Text] [Related]  

  • 35. The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2011 Feb; 41(2):167-75. PubMed ID: 21039444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of metabolic syndrome with coronary atherosclerosis in non-diabetic postmenopausal women.
    Yun BH; Chon SJ; Lee YJ; Han EJ; Cho S; Choi YS; Lee BS; Seo SK
    Climacteric; 2015 Apr; 18(2):284-9. PubMed ID: 25233795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression, coronary artery disease, type 2 diabetes, metabolic syndrome and quality of life in Taiwanese adults from a cardiovascular department of a major hospital in Southern Taiwan.
    Huang CY; Chi SC; Sousa VD; Wang CP; Pan KC
    J Clin Nurs; 2011 May; 20(9-10):1293-302. PubMed ID: 21492275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvascular disease relevance in the hypertension syndrome.
    Abarquez RF
    Clin Hemorheol Microcirc; 2003; 29(3-4):295-300. PubMed ID: 14724354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolic syndrome in type 1 diabetes: does it exist and does it matter?
    McGill M; Molyneaux L; Twigg SM; Yue DK
    J Diabetes Complications; 2008; 22(1):18-23. PubMed ID: 18191073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods to investigate coronary microvascular function in clinical practice.
    Lanza GA; Camici PG; Galiuto L; Niccoli G; Pizzi C; Di Monaco A; Sestito A; Novo S; Piscione F; Tritto I; Ambrosio G; Bugiardini R; Crea F; Marzilli M;
    J Cardiovasc Med (Hagerstown); 2013 Jan; 14(1):1-18. PubMed ID: 23222188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.